Zimmer Biomet Holdings logo

Zimmer Biomet Holdings Income Statement

Revenue, expenses, and profitability over time

Zimmer Biomet Holdings generated $8.4B in trailing twelve-month revenue, up 0.1% year-over-year. Net income was $761.1M with a 9.05% net margin. Gross margin stands at 70.03% and operating margin at 14.02%. Diluted EPS is $3.86, which declined 0.1% year-over-year. Based on the Q1 2026 filing.

Latest FilingQ1 2026
Report Date2026-05-01
Market Cap$16.0B
P/E Ratio21.05
ROE6.07%

Tax

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Income tax expense$48.9M$46.5M$71.2M$48.0M$63.0M